Lyell Immunopharma Newsroom

HC Wainwright & Co. Reiterates Neutral on Lyell Immunopharma, Maintains $1 Price Target

BenzingaNov 12 19:46

Mitchell Kapoor Maintains Hold Rating on Lyell Immunopharma Amid Promising IMPT-314 Results and Market Challenges

TipRanksNov 12 19:18

Lyell Immunopharma Cut to Underperform From Buy by B of A Securities

Dow JonesOct 30 20:18

Lyell Immunopharma Price Target Maintained With a $1.00/Share by HC Wainwright & Co.

Dow JonesOct 28 20:23

Lyell Immunopharma Analyst Ratings

BenzingaOct 28 20:13

H.C. Wainwright Downgrades Lyell Immunopharma(LYEL.US) to Hold Rating, Cuts Target Price to $1

Futu NewsOct 28 18:33

Neutral Rating for Lyell Immunopharma Amid Strategic Shifts and Competitive Challenges

TipRanksOct 28 18:18

Lyell Immunopharma Analyst Ratings

BenzingaAug 19 19:49

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Lyell Immunopharma (LYEL) and Janux Therapeutics Inc (JANX)

TipRanksAug 19 18:22

B of A Securities Maintains Buy on Lyell Immunopharma, Lowers Price Target to $6

BenzingaJun 28 01:29

HC Wainwright & Co. Downgrades Lyell Immunopharma to Neutral, Lowers Price Target to $1

BenzingaJun 27 18:46

Lyell Immunopharma Analyst Ratings

BenzingaJun 27 18:44

Bank of America Securities Keeps Their Buy Rating on Lyell Immunopharma (LYEL)

TipRanksMay 13 21:46

Lyell Immunopharma Analyst Ratings

BenzingaMay 7 18:50

Lyell Immunopharma Analyst Ratings

BenzingaMar 1 04:19

HC Wainwright & Co. Maintains Buy on Lyell Immunopharma, Lowers Price Target to $8

BenzingaNov 9, 2023 20:38

Lyell Immunopharma Analyst Ratings

BenzingaNov 9, 2023 20:37

Promising Financial and Clinical Prospects: A Comprehensive Buy Rating Analysis for Lyell Immunopharma

TipRanksNov 9, 2023 19:46

JP Morgan Downgrades Lyell Immunopharma to Neutral, Lowers Price Target to $5

BenzingaAug 28, 2023 16:48

Lyell Immunopharma Analyst Ratings

BenzingaAug 28, 2023 16:47